New York, New York 10032

  • Coronary Heart Disease


The purpose of this study is to examine the effect of a brief electronic shared decision making (eSDM) intervention on depressive symptoms in coronary heart disease patients with elevated depressive symptoms.

Study summary:

Depression is common in patients with coronary heart disease and associated with increased cardiac morbidity and mortality. Treating depressive symptoms appears to improve depressive symptoms and quality of life. Despite expert recommendations to screen and treat depressive symptoms fewer coronary heart disease patients engage in depression treatment than the general population, perhaps due to 1) sub-optimal provider awareness and referral rates and 2) low self-efficacy, stigma and misattribution of depressive symptoms among coronary heart disease patients. In addition, few real world theory-informed implementation trials exist for improving screening and treatment in outpatient settings. The specific aim is to determine whether an electronic shared decision making (eSDM) and behavioral activation tool improves depressive symptoms and treatment initiation in coronary heart disease patients with elevated depressive symptoms. To accomplish these aims, a hybrid effectiveness-implementation trial will be conducted using a stepped wedge design across socioeconomically diverse cardiology and primary care clinics.


Inclusion Criteria: - History of coronary heart disease - English or Spanish Speaking - Elevated Depressive symptoms (PHQ9 ≥10) Exclusion Criteria: - Under the care of a psychiatrist (e.g., for schizophrenia) - Diagnosis/history of psychosis or schizophrenia - Diagnosis/history of bipolar disorder - Attempted suicide - Non-English or Spanish speaking - Dementia or severe cognitive impairment - Non-elevated depressive symptoms - Alcohol or substance abuse - Pregnancy



Primary Contact:

Principal Investigator
Nathalie Moise, MD, MS
Columbia University

Nathalie Moise, MD, MS
Phone: 2123422889

Backup Contact:


Location Contact:

New York, New York 10032
United States

Nathalie Moise, MD, MS
Phone: 212-342-2889

Site Status: Recruiting

Data Source:

Date Processed: June 28, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.